IBBQ vs. IDNA
IBBQ (Invesco Nasdaq Biotechnology ETF) and IDNA (iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund) are both Health & Biotech Equities funds - IBBQ tracks the NASDAQ / Biotechnology while IDNA tracks the NYSE FactSet Global Genomics and Immuno Biopharma Index. Both are passively managed. Over the past 3 years, IBBQ returned 12.60%/yr vs 6.74%/yr for IDNA. Their correlation of 0.90 suggests significant overlap in exposure. IBBQ charges 0.00%/yr vs 0.47%/yr for IDNA.
Performance
IBBQ vs. IDNA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IBBQ achieves a 1.91% return, which is significantly lower than IDNA's 10.31% return.
IBBQ
- 1D
- 1.77%
- 1M
- -1.63%
- YTD
- 1.91%
- 6M
- 0.94%
- 1Y
- 39.72%
- 3Y*
- 12.60%
- 5Y*
- —
- 10Y*
- —
IDNA
- 1D
- 0.73%
- 1M
- -2.56%
- YTD
- 10.31%
- 6M
- 8.52%
- 1Y
- 40.87%
- 3Y*
- 6.74%
- 5Y*
- -8.42%
- 10Y*
- —
IBBQ vs. IDNA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
IBBQ Invesco Nasdaq Biotechnology ETF | 1.91% | 33.32% | -0.63% | 4.73% | -10.41% | -6.72% |
IDNA iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | 10.31% | 17.26% | -0.72% | -7.63% | -42.28% | -11.50% |
Correlation
The correlation between IBBQ and IDNA is 0.88, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.88 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.89 |
Correlation (All Time) Calculated using the full available price history since Jun 14, 2021 | 0.90 |
The correlation between IBBQ and IDNA has been stable across timeframes, ranging from 0.88 to 0.90 - a consistent structural relationship.
IBBQ vs. IDNA - Sectors Allocation Comparison
Sectors
IBBQ
IDNA
Healthcare
Financial Services
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Industrials
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
IBBQ
IDNA
Financial Services
IBBQ
IDNA
-
Basic Materials
IBBQ
-
IDNA
-
Communication Services
IBBQ
-
IDNA
-
Consumer Cyclical
IBBQ
-
IDNA
-
Consumer Defensive
IBBQ
-
IDNA
-
Energy
IBBQ
-
IDNA
-
Industrials
IBBQ
-
IDNA
Real Estate
IBBQ
-
IDNA
-
Technology
IBBQ
-
IDNA
-
Utilities
IBBQ
-
IDNA
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IBBQ vs. IDNA — Risk / Return Rank
IBBQ
IDNA
IBBQ vs. IDNA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco Nasdaq Biotechnology ETF (IBBQ) and iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| IBBQ | IDNA | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 2.03 | 1.68 | +0.35 |
Sortino ratioReturn per unit of downside risk | 2.86 | 2.44 | +0.42 |
Omega ratioGain probability vs. loss probability | 1.34 | 1.27 | +0.06 |
Calmar ratioReturn relative to maximum drawdown | 4.79 | 3.85 | +0.94 |
Martin ratioReturn relative to average drawdown | 15.68 | 10.98 | +4.70 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| IBBQ | IDNA | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.03 | 1.68 | +0.35 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | -0.30 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.16 | 0.10 | +0.06 |
Drawdowns
IBBQ vs. IDNA - Drawdown Comparison
The maximum IBBQ drawdown since its inception was -37.94%, smaller than the maximum IDNA drawdown of -68.26%. Use the drawdown chart below to compare losses from any high point for IBBQ and IDNA.
Loading charts...
Drawdown Indicators
| IBBQ | IDNA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -37.94% | -68.26% | +30.32% |
Max Drawdown (1Y)Largest decline over 1 year | -8.34% | -10.66% | +2.32% |
Max Drawdown (3Y)Largest decline over 3 years | -23.66% | -29.73% | +6.07% |
Max Drawdown (5Y)Largest decline over 5 years | — | -68.26% | — |
Current DrawdownCurrent decline from peak | -5.17% | -45.61% | +40.44% |
Average DrawdownAverage peak-to-trough decline | -16.82% | -36.24% | +19.42% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.54% | 3.73% | -1.19% |
Volatility
IBBQ vs. IDNA - Volatility Comparison
Invesco Nasdaq Biotechnology ETF (IBBQ) and iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) have volatilities of 6.84% and 7.18%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IBBQ | IDNA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.84% | 7.18% | -0.34% |
Volatility (6M)Calculated over the trailing 6-month period | 15.14% | 17.98% | -2.84% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.63% | 24.48% | -4.85% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.86% | 28.42% | -6.56% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 21.86% | 29.53% | -7.67% |
IBBQ vs. IDNA - Expense Ratio Comparison
IBBQ has a 0.00% expense ratio, which is lower than IDNA's 0.47% expense ratio.
Dividends
IBBQ vs. IDNA - Dividend Comparison
IBBQ's dividend yield for the trailing twelve months is around 0.87%, less than IDNA's 1.07% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
IBBQ Invesco Nasdaq Biotechnology ETF | 0.87% | 0.90% | 1.14% | 0.81% | 0.76% | 0.63% | 0.00% | 0.00% |
IDNA iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | 1.07% | 1.18% | 0.98% | 1.04% | 0.54% | 0.70% | 0.26% | 0.80% |
Frequently Asked Questions
IBBQ and IDNA have a correlation of 0.88, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IDNA has higher volatility (7.18%) compared to IBBQ (6.84%). In terms of maximum drawdown, IBBQ dropped -37.94% vs IDNA's -68.26%.
On 3-year performance, IBBQ leads with 12.60% vs 6.74% for IDNA. On fees, IBBQ is cheaper at 0.00% per year. On volatility, IBBQ has been the lower-risk option at 6.84%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 3-year period, IBBQ has performed better with a 12.60% return vs 6.74%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
IBBQ is cheaper with a 0.00% expense ratio, compared with 0.47% for IDNA.
IDNA has the higher dividend yield at 1.07%, compared with 0.87% for IBBQ.
IBBQ tracks NASDAQ / Biotechnology, while IDNA tracks NYSE FactSet Global Genomics and Immuno Biopharma Index. They also come from different issuers: Invesco and iShares. Their fees differ too: 0.00% for IBBQ and 0.47% for IDNA.
IBBQ currently has the higher Sharpe Ratio (2.03 vs 1.68), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IBBQ and IDNA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer